{"id":"amlodipine-plus-losartan","safety":{"commonSideEffects":[{"rate":"5-10","effect":"Peripheral edema"},{"rate":"3-7","effect":"Dizziness"},{"rate":"2-5","effect":"Headache"},{"rate":"2-4","effect":"Fatigue"},{"rate":"1-3","effect":"Hyperkalemia"},{"rate":"1-2","effect":"Cough"}]},"_chembl":{"chemblId":"CHEMBL1200402","moleculeType":"Small molecule","molecularWeight":"567.06"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Amlodipine is a dihydropyridine calcium channel blocker that prevents calcium influx into vascular smooth muscle cells, causing vasodilation. Losartan is an angiotensin II receptor blocker (ARB) that blocks AT1 receptors, preventing angiotensin II-mediated vasoconstriction and aldosterone release. The combination provides complementary antihypertensive effects through two distinct mechanisms.","oneSentence":"Amlodipine and losartan work together to lower blood pressure by relaxing blood vessels through calcium channel blockade and angiotensin II receptor antagonism.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:44:39.750Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"}]},"trialDetails":[{"nctId":"NCT05370599","phase":"PHASE2","title":"Hypertension in Young Adults Trial","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2022-04-15","conditions":"Hypertension","enrollment":36},{"nctId":"NCT07262710","phase":"","title":"Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study","status":"NOT_YET_RECRUITING","sponsor":"First Teaching Hospital of Tianjin University of Traditional Chinese Medicine","startDate":"2025-12-01","conditions":"Post-stroke Pneumonia","enrollment":13656},{"nctId":"NCT06796660","phase":"EARLY_PHASE1","title":"Exploring the Impact of Nephropathy Formula No. 1 on Chronic Kidney Disease Patients","status":"NOT_YET_RECRUITING","sponsor":"Liu Zhanghong","startDate":"2025-09-01","conditions":"Renal Insufficiency, Chronic","enrollment":70},{"nctId":"NCT06150560","phase":"PHASE3","title":"A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2024-04-01","conditions":"Coarctation of Aorta, High Blood Pressure","enrollment":120},{"nctId":"NCT04158154","phase":"NA","title":"Transforming Hypertension Treatment in Nigeria Using a Type II Hybrid, Interrupted Time Series Design","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2020-02-01","conditions":"Hypertension","enrollment":21922},{"nctId":"NCT06495710","phase":"NA","title":"Arterial Stiffness and Blood Pressure","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2025-05-01","conditions":"Hypertension, Vascular Stiffness, Aging","enrollment":228},{"nctId":"NCT00140959","phase":"PHASE4","title":"Losartan and HCTZ and Amlodipine vs Atenolol and Amlodipine (0954A-309)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-02-01","conditions":"Hypertension","enrollment":120},{"nctId":"NCT06515678","phase":"","title":"Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"Groupe Hospitalier Pitie-Salpetriere","startDate":"2024-05-20","conditions":"Ovarian Cancer, Antiangiogenic-Associated Hypertension, Adjuvant Bevacizumab","enrollment":9464},{"nctId":"NCT05479097","phase":"NA","title":"Feasibility Study of a Novel mHealth Application to Enable Community Health Workers to Manage","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2023-02-06","conditions":"Hypertension","enrollment":32},{"nctId":"NCT01277822","phase":"PHASE4","title":"Efficacy of Losartan + Amlodipine Compared to Amlodipine Alone in the Treatment of Uncontrolled High Blood Pressure (MK-0954F-399)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2011-05-30","conditions":"Hypertension","enrollment":334},{"nctId":"NCT06366386","phase":"","title":"Integrating Hypertension Management in DSD for HIV","status":"NOT_YET_RECRUITING","sponsor":"Infectious Diseases Research Collaboration, Uganda","startDate":"2024-06-15","conditions":"Hypertension, HIV","enrollment":1100},{"nctId":"NCT00568178","phase":"PHASE3","title":"An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2))","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-06-01","conditions":"Proteinuria","enrollment":306},{"nctId":"NCT05954884","phase":"NA","title":"Community-based HEARTS Intervention (Pilot)","status":"UNKNOWN","sponsor":"National Heart Foundation of Bangladesh","startDate":"2023-08-01","conditions":"Hypertension","enrollment":400},{"nctId":"NCT05843162","phase":"PHASE4","title":"A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome","status":"UNKNOWN","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2023-06-01","conditions":"Essential Hypertension, Metabolic Syndrome","enrollment":116},{"nctId":"NCT03666351","phase":"PHASE4","title":"Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2018-10-18","conditions":"Aortic Stenosis, Aortic Regurgitation, Hypertension","enrollment":128},{"nctId":"NCT03461003","phase":"PHASE4","title":"N-of-1 Trials In Children With Hypertension","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2018-04-02","conditions":"Pediatric Hypertension","enrollment":49},{"nctId":"NCT05462535","phase":"","title":"An Observational Study to Evaluate Effectiveness and Safety of Amosartan Plus Tablet","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2018-02-26","conditions":"Hypertension,Essential","enrollment":4785},{"nctId":"NCT03897868","phase":"PHASE2","title":"A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2019-03-21","conditions":"Hypertension","enrollment":248},{"nctId":"NCT05450575","phase":"","title":"An Observational Study to Evaluate Effectiveness and Safety of Amosartan Q Tablet","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2018-04-17","conditions":"Hypertension, Dyslipidemia","enrollment":5400},{"nctId":"NCT00140985","phase":"PHASE4","title":"Antiproteinuric Efficacy of Losartan Potassium in Patients With Non-Diabetic Proteinuric Renal Diseases (0954-213)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2000-02","conditions":"Renal Disorder","enrollment":97},{"nctId":"NCT01041807","phase":"","title":"Cozaar XQ Re-examination Study (MK-0954-349)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2010-02","conditions":"Hypertension","enrollment":669},{"nctId":"NCT05212597","phase":"PHASE2","title":"Open Label RCT for Chronic Severe AR : Entresto vs. CCB/ARB","status":"UNKNOWN","sponsor":"Samsung Medical Center","startDate":"2022-01-12","conditions":"Aortic Valve Insufficiency","enrollment":100},{"nctId":"NCT04191681","phase":"PHASE4","title":"Safety and Efficacy of ARNI After LVAD ImplanT (SEAL-IT) Study","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2019-11-08","conditions":"Stage D Heart Failure","enrollment":50},{"nctId":"NCT04467931","phase":"","title":"ACEI or ARB and COVID-19 Severity and Mortality in US Veterans","status":"COMPLETED","sponsor":"University of Utah","startDate":"2020-01-19","conditions":"Hypertension, COVID","enrollment":22213},{"nctId":"NCT00159692","phase":"PHASE4","title":"Amlodipine Diabetic Hypertension Efficacy Response Trial","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2003-03","conditions":"Hypertension","enrollment":739},{"nctId":"NCT04074551","phase":"PHASE3","title":"A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2019-07-16","conditions":"Hypertension, Dyslipidemias","enrollment":145},{"nctId":"NCT03978884","phase":"PHASE4","title":"Phase 4 Study of the Efficacy of Losartan Based Therapy in Hypertensives With and Without Diabetes","status":"WITHDRAWN","sponsor":"The University of The West Indies","startDate":"2019-06-01","conditions":"Diabetes Mellitus, Hypertension","enrollment":""},{"nctId":"NCT04330300","phase":"PHASE4","title":"Coronavirus (COVID-19) ACEi/ARB Investigation","status":"SUSPENDED","sponsor":"National University of Ireland, Galway, Ireland","startDate":"2020-04-30","conditions":"Hypertension, COVID-19","enrollment":2414},{"nctId":"NCT03912285","phase":"PHASE1","title":"The Pharmacokinetic Interaction Between Amlodipine and Losartan","status":"COMPLETED","sponsor":"Korea University Anam Hospital","startDate":"2008-01-10","conditions":"Healthy","enrollment":24},{"nctId":"NCT02744456","phase":"EARLY_PHASE1","title":"N-of-1 Trials for Blood Pressure Medications in Adults","status":"COMPLETED","sponsor":"Columbia University","startDate":"2014-08-01","conditions":"Hypertension, High Blood Pressure","enrollment":10},{"nctId":"NCT01302691","phase":"PHASE3","title":"MK-0954E Study in Participants With Hypertension (MK-0954E-357)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2011-01-01","conditions":"Hypertension","enrollment":327},{"nctId":"NCT03626259","phase":"PHASE4","title":"Losartan/Amlodipine on Hemodynamics Parameters and Arterial Stiffness in Arterial Hypertension","status":"UNKNOWN","sponsor":"Centro Universitario de Ciencias de la Salud, Mexico","startDate":"2018-08-06","conditions":"Hypertension","enrollment":28},{"nctId":"NCT03578042","phase":"PHASE4","title":"Fixed-Free HTN Trial","status":"UNKNOWN","sponsor":"Hotel Dieu de France Hospital","startDate":"2017-04-01","conditions":"Hypertension","enrollment":100},{"nctId":"NCT01797926","phase":"PHASE1","title":"Study to Determine the Bioequivalence of Two Fixed Dose Combination (FDC) Tablet Formulations of Amlodipine and Losartan FDC5/50 and FDC5/100 Under Fasting Conditions","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2013-05-23","conditions":"Hypertension","enrollment":102},{"nctId":"NCT01964079","phase":"PHASE4","title":"Comparision of Blood Pressure Variability Between Amlodipine and Losartan","status":"COMPLETED","sponsor":"Wonju Severance Christian Hospital","startDate":"2013-04","conditions":"Hypertension","enrollment":144},{"nctId":"NCT02294539","phase":"PHASE4","title":"Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive Patients","status":"COMPLETED","sponsor":"Chong-Jin Kim","startDate":"2014-08","conditions":"Hypertension","enrollment":231},{"nctId":"NCT02232880","phase":"PHASE2","title":"Treatment of Resistant Hypertension by Prevention of T-Cell Co-Stimulation","status":"TERMINATED","sponsor":"Vanderbilt University Medical Center","startDate":"2014-08","conditions":"Hypertension","enrollment":1},{"nctId":"NCT00940667","phase":"PHASE3","title":"Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Essential Hypertension","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2008-05","conditions":"Hypertension","enrollment":185},{"nctId":"NCT02900729","phase":"PHASE3","title":"Randomized Controlled Trial of Renal Denervation for Resistant Hypertension","status":"UNKNOWN","sponsor":"Shanghai WiseGain Medical Devices Co., Ltd.","startDate":"2016-10","conditions":"Hypertension","enrollment":254},{"nctId":"NCT01603940","phase":"PHASE4","title":"Comparison Between Losartan and Benazepril in Diabetic Hypertensive Patients Not Controlled by Amlodipine","status":"COMPLETED","sponsor":"Hospital Universitario Pedro Ernesto","startDate":"2012-05","conditions":"Hypertension, Diabetes Mellitus","enrollment":30},{"nctId":"NCT00805311","phase":"PHASE4","title":"Aggressive Medical Treatment Evaluation for Asymptomatic Carotid Artery Stenosis","status":"TERMINATED","sponsor":"Russian Cardiology Research and Production Center","startDate":"2009-04","conditions":"Carotid Artery Stenosis, Atherosclerosis, Stroke","enrollment":400},{"nctId":"NCT00492128","phase":"PHASE4","title":"Kanagawa Combination Anti-hypertensive Therapy (K-CAT)","status":"COMPLETED","sponsor":"Yokohama City University Medical Center","startDate":"2007-09","conditions":"Hypertension","enrollment":196},{"nctId":"NCT01176032","phase":"PHASE4","title":"ALiskiren or Losartan Effects on bioMARKers of Myocardial Remodeling","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2010-06","conditions":"Hypertension, Left Ventricle Hypertrophy","enrollment":74},{"nctId":"NCT01713647","phase":"PHASE1","title":"Bioequivalence Study of Amlodipine / Losartan/ Hydrochlorothiazide of PHARMALINE, Lebanon Under Fastion Conditions","status":"COMPLETED","sponsor":"Pharmaceutical Research Unit, Jordan","startDate":"2012-10","conditions":"Fasting","enrollment":39},{"nctId":"NCT01828359","phase":"PHASE4","title":"The Efficacy and Safety Study of Anti-hypertension Combination Drug in Patients Uncontrolled With Monotherapy.","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2010-08","conditions":"Hypertension","enrollment":199},{"nctId":"NCT01198496","phase":"PHASE4","title":"Recurrent Stroke Prevention Clinical Outcome Study","status":"UNKNOWN","sponsor":"Biomedis International Ltd.","startDate":"2010-10","conditions":"Hypertension, Stroke, Blood Pressure","enrollment":5000},{"nctId":"NCT01180413","phase":"PHASE4","title":"Intensive Vasodilator Therapy in Patients With Essential Hypertension","status":"COMPLETED","sponsor":"Aarhus University Hospital","startDate":"2010-12","conditions":"Essential Hypertension, High Blood Pressure","enrollment":48},{"nctId":"NCT01409408","phase":"PHASE4","title":"Comparison of Amlodipine and Aliskiren in Diabetic Hypertensive Patient With Blood Pressure Not Controlled by Losartan","status":"WITHDRAWN","sponsor":"Hospital Universitario Pedro Ernesto","startDate":"2011-04","conditions":"Hypertension, Diabetes Mellitus","enrollment":""},{"nctId":"NCT00237588","phase":"PHASE4","title":"Glucose Optimisation With Angiotensin II Antagonist Losartan (GOAAL)","status":"COMPLETED","sponsor":"Ullevaal University Hospital","startDate":"2004-12","conditions":"Hypertension","enrollment":25},{"nctId":"NCT00446563","phase":"PHASE3","title":"Efficacy and Safety of Valsartan in Combination With Amlodipine Compared to Losartan Plus Hydrochlorothiazide in Patients With Hypertension and Left Ventricular Hypertrophy","status":"COMPLETED","sponsor":"Novartis","startDate":"2007-03","conditions":"Hypertension; Hypertrophy, Left Ventricular","enrollment":90},{"nctId":"NCT01271374","phase":"PHASE4","title":"Changes in Endothelial Function and Biomarkers in African Americans (AA) With Metabolic Syndrome","status":"UNKNOWN","sponsor":"InVasc Therapeutics, Inc.","startDate":"2010-04","conditions":"Hypertension","enrollment":80},{"nctId":"NCT01197014","phase":"PHASE1","title":"A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2010-09","conditions":"Healthy","enrollment":72},{"nctId":"NCT01197001","phase":"PHASE1","title":"A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2010-08","conditions":"Healthy","enrollment":72},{"nctId":"NCT01198249","phase":"PHASE1","title":"Pharmacokinetic Drug Interactions Between Single and Concomitant Administrations of Amlodipine, Losartan, and Hydrochlorothiazide in Subjects With (Pre)Hypertension","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2010-09","conditions":"Essential Hypertension","enrollment":23},{"nctId":"NCT00931710","phase":"PHASE4","title":"Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension","status":"COMPLETED","sponsor":"Novartis","startDate":"2009-07","conditions":"Stage 2 Systolic Hypertension","enrollment":488},{"nctId":"NCT01127217","phase":"PHASE3","title":"Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Stage 2 Hypertension","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2009-05","conditions":"Hypertension","enrollment":149},{"nctId":"NCT00942344","phase":"PHASE2","title":"Efficacy and Safety of Amlodipine and Losartan in Patients With Essential Hypertension","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2007-05","conditions":"Hypertension","enrollment":320},{"nctId":"NCT00940680","phase":"PHASE3","title":"Efficacy/Safety of Amlodipine Plus Losartan Versus Losartan in Patients With Essential Hypertension","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2008-04","conditions":"Hypertension","enrollment":142},{"nctId":"NCT00813722","phase":"PHASE4","title":"Effect of Active Telephone Calls in the Compliance of Hypertensive Patients With Treatment","status":"UNKNOWN","sponsor":"University of Sao Paulo","startDate":"1999-03","conditions":"Blood Pressure","enrollment":400},{"nctId":"NCT00669435","phase":"PHASE4","title":"Losartan and Simvastatin in Hypertensive Obeses With Liver Steatosis","status":"UNKNOWN","sponsor":"University of Pavia","startDate":"2008-04","conditions":"Hypertension","enrollment":75},{"nctId":"NCT00659451","phase":"PHASE3","title":"Effects Of Losartan On Myocardial Structure In Diabetic Hypertensive Patients With Left Ventricular","status":"UNKNOWN","sponsor":"University of Pavia","startDate":"2008-04","conditions":"Essential Hypertension, Diabetes Mellitus","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":29,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Amosartan"],"phase":"phase_3","status":"active","brandName":"Amlodipine plus Losartan","genericName":"Amlodipine plus Losartan","companyName":"Hanmi Pharmaceutical Company Limited","companyId":"hanmi-pharmaceutical-company-limited","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Amlodipine and losartan work together to lower blood pressure by relaxing blood vessels through calcium channel blockade and angiotensin II receptor antagonism. Used for Hypertension.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}